Last updated: January 8, 2022
Sponsor: Universidade do Porto
Overall Status: Active - Recruiting
Phase
N/A
Condition
Musculoskeletal Diseases
Arthritis And Arthritic Pain
Ankylosing Spondylitis
Treatment
N/AClinical Study ID
NCT04386538
alexandracardoso
Ages 18-75 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Age between 18 and 75 years old
- Available to comply with study protocol
- Ability to read and sign the Informed Consent
- Diagnosis of Ankylosing Spondylitis performed by the rheumatologist, according to theASAS classification criteria, revised in 2016
- Positive HLA-B27allele
- Stable dose therapy within 3 months before selection
Exclusion
Exclusion Criteria:
- Pregnant, breastfeeding or planning to become pregnant within the study period
- Prior or current clinical history of drug or other substances abuse
- Subjects with uncontrolled clinical conditions, like neoplastic diseases, renalfailure, liver impairment, uncompensated cardiac disease
- Dietetic restrictions due to religious believes or others incompatible with the studyprotocol
- Impossibility to attend to the mandatory personal clinical evaluation
- Presence of pacemaker, making impossible to perform the impedance body compositionanalysis
- Change in therapy during the intervention period
Study Design
Total Participants: 150
Study Start date:
January 03, 2022
Estimated Completion Date:
December 30, 2022
Study Description
Connect with a study center
Instituto Português de Reumatologia
Lisboa,
PortugalActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.